Skip to main content

US ClosedU.S. Closed

RGNX: REGENXBIO Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates.

52W Range

39thpctl

Volume

0.99×avg

Market Cap

499.40MUSD

P/E Ratio

-2.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

REGENXBIO Inc.

RGNXNASDAQ Global Select·USD·Closed

REGENXBIO Inc.

RGNXNASDAQ·USD·Closed

$9.66

+3.09%

$9.66

+$0.29 (3.09%)

52W Range

39thpctl

Volume

0.99×avg

Mkt Cap

499.40MUSD

P/E

-2.5TTM

Div Yield

–ann